Zusammenfassung
Die Aufmerksamkeitsdefizit/-Hyperaktivitätsstörung (ADHS) ist eine chronische Verhaltensstörung, die in Deutschland bei 4,8 % aller Kinder und Jugendlichen diagnostiziert wird. Obwohl viele Studien überwiegend neurobiologische Ursachen für ADHS nahelegen, lässt sich die Erkrankung noch nicht anhand entsprechender biologischer Marker diagnostizieren. Im Mittelpunkt der Diagnose steht die Einschätzung eines erfahrenen Klinikers, wobei die Abgrenzung zu anderen psychischen Erkrankungen bedeutsam ist. An Risikofaktoren sind neben der Veranlagung u. a. die Nikotinexposition des Kindes während der Schwangerschaft, ungünstige psychosoziale Umstände und Geburtskomplikationen bekannt. Als Schutzfaktoren haben sich die kognitive Begabung, günstige Sozialkontakte und eine frühe Behandlung erwiesen. Die erforderlichen Versorgungsstrukturen entwickeln sich, bedürfen aber noch erheblicher Verbesserung. Studien über die Lebensqualität betroffener Kinder zeigen, dass diese in nahezu allen Bereichen erheblich eingeschränkt ist.
Abstract
Attention-deficit hyperactivity disorder (ADHD) is a chronic behavioural disorder diagnosed in 4.8 % of German children and adolescents. Although many studies indicate primarily a neurobiological etiology, the disorder cannot be diagnosed on the basis of specific markers. The principal aspect of diagnosis is the experienced clinician who must also take the differentiation of other behavioural disorders into account. In addition to inheritance, other known risk factors are nicotine exposition in pregnancy, adverse psychosocial conditions and birth complications. Protective factors are cognitive abilities, positive social contacts, and early treatment. The necessary structures in community support are developing; however, substantial enhancement is needed. Studies on quality of life indicate that ADHD should not be reduced to core symptoms since affected children are impaired in almost all areas of daily life.
Literatur
Polanczyk G, de Lima MS, Horta BL, et al. (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 6:942–948
Schlack R, Holling H, Kurth BM, Huss M (2007) The prevalence of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. Initial results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsbl Gesundheitsforschung Gesundheitsschutz 5–6:827–835
Jensen PS (2000) ADHD: current concepts on etiology, pathophysiology, and neurobiology. Child Adolesc Psychiatr Clin N Am 3:557-viii
Biederman J (2007) Advances in the neurobiology of ADHD. CNS Spectr 4(Suppl 6):6–7
Wickens JR, Tripp G, Gerhardt GA (2007) Neurobiology of attention-deficit hyperactivity disorder (ADHD): from gene to therapy. J Neurosci Methods 2:293
Castellanos FX, Lee PP, Sharp W, et al. (2002) Developmental trajectories of brain volume abnormalities in children and adolescents with attentiondeficit/ hyperactivity disorder. Jama 14:1740–1748
Alexander DM, Hermens DF, Keage HA, et al. (2008) Event-related wave activity in the EEG provides new marker of ADHD. Clin Neurophysiol 1:163–179
Mahone EM, Powell SK, Loftis CW, et al. (2006) Motor persistence and inhibition in autism and ADHD. J Int Neuropsychol Soc 5:622–631
Mahone EM, Koth CW, Cutting L, et al. (2001) Executive function in fluency and recall measures among children with Tourette syndrome or ADHD. J Int Neuropsychol Soc 1:102–111
Nair J, Ehimare U, Beitman BD, et al. (2006) Clinical review: evidence-based diagnosis and treatment of ADHD in children. Mo Med 6:617–621
Jensen PS (2001) Introduction – ADHD comorbidity and treatment outcomes in the MTA. J Am Acad Child Adolesc Psychiatry 2:134–136
Jensen PS, Hinshaw SP, Kraemer HC, et al. (2001) ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2:147–158
Arcos-Burgos M, Castellanos FX, Lopera F, et al. (2002) Attention-deficit/hyperactivity disorder (ADHD): feasibility of linkage analysis in a genetic isolate using extended and multigenerational pedigrees. Clin Genet 5:335–343
Swanson JM, Flodman P, Kennedy J, et al. (2000) Dopamine genes and ADHD. Neurosci Biobehav Rev 1:21–25
Laucht M, Hohm E, Esser G, et al. (2007) Association between ADHD and smoking in adolescence: shared genetic, environmental and psychopathological factors. J Neural Transm 8:1097–1104
Becker K, El Faddagh M, Schmidt MH, et al. (2008) Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. J Pediatr 2:263–269
Rodriguez A, Bohlin G (2005) Are maternal smoking and stress during pregnancy related to ADHD symptoms in children? J.Child Psychol Psychiatry 3:246–254
Carter S, Paterson J, Gao W, Iusitini L (2008) Maternal smoking during pregnancy and behaviour problems in a birth cohort of 2-year-old Pacific children in New Zealand. Early Hum Dev 1:59–66
Curtis LT, Patel K (2008) Nutritional and Environmental Approaches to Preventing and Treating Autism and Attention Deficit Hyperactivity Disorder (ADHD): A Review. J Altern Complement Med 14(1):79–85
Levy F, Barr C, Sunohara G (1998) Directions of aetiologic research on attention deficit hyperactivity disorder. Aust N.Z.J Psychiatry 1:97–103
McCann D, Barrett A, Cooper A, et al. (2007) Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 9598:1560–1567
Lou HC (1996) Etiology and pathogenesis of attention- deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy. Acta Paediatr 11:1266–1271
Scahill L, Schwab-Stone M, Merikangas KR, et al. (1999) Psychosocial and clinical correlates of ADHD in a community sample of school-age children. J Am Acad Child Adolesc Psychiatry 8:976–984
Nigg J, Nikolas M, Friderici K, et al. (2007) Genotype and neuropsychological response inhibition as resilience promoters for attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder under conditions of psychosocial adversity. Dev Psychopathol 3:767–786
Escobar R, Soutullo CA, Hervas A, et al. (2005) Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children. Pediatrics 3:e364–e369
Matza LS, Johnston JA, Faries DE, et al. (2007) Responsiveness of the Adult Attention-Deficit/ Hyperactivity Disorder Quality of Life Scale (AAQoL). Qual Life Res 9:1511–1520
Levin FR, Upadhyaya HP (2007) Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis. J Clin Psychiatry 7:e18
Bessou H, Zeeb H, Puteanus U (2007) Methylphenidate prescriptions in the city of Cologne: overrepresentation of privately insured patients. Results of an analysis based on prescription data. Gesundheitswesen 5:292–296
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huss, M. ADHS bei Kindern: Risikofaktoren, Schutzfaktoren, Versorgung, Lebensqualität. Bundesgesundheitsbl. 51, 602–605 (2008). https://doi.org/10.1007/s00103-008-0538-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00103-008-0538-1